Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Retained Earnings (2018 - 2025)

TELA Bio (TELA) has 8 years of Retained Earnings data on record, last reported at -$388.5 million in Q3 2025.

  • For Q3 2025, Retained Earnings fell 260838.26% year-over-year to -$388.5 million; the TTM value through Sep 2025 reached -$388.5 million, down 260838.26%, while the annual FY2024 figure was -$358.7 million, 11.79% down from the prior year.
  • Retained Earnings reached -$388.5 million in Q3 2025 per TELA's latest filing, down from $93000.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $262000.0 in Q3 2022 and bottomed at -$388.5 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$170.8 million, with a median of -$221.3 million recorded in 2021.
  • Peak YoY movement for Retained Earnings: plummeted 1775466.67% in 2021, then surged 100.12% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$52000.0 in 2021, then plummeted by 527255.77% to -$274.2 million in 2022, then fell by 17.02% to -$320.9 million in 2023, then decreased by 11.79% to -$358.7 million in 2024, then decreased by 8.3% to -$388.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$388.5 million in Q3 2025, $93000.0 in Q2 2025, and -$370.0 million in Q1 2025.